These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3029003)

  • 1. Cytogenetic effects of multiagent chemotherapy on the peripheral lymphocytes of patients with small cell lung cancer.
    Tominaga K; Shinkai T; Saijo N; Eguchi K; Sasaki Y; Sakurai M; Suga J; Nakajima T; Ochi H; Suemasu K
    Jpn J Cancer Res; 1986 Dec; 77(12):1241-8. PubMed ID: 3029003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
    Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small cell carcinoma of the esophagus with reference to alternating multiagent chemotherapy: report of two cases.
    Koide N; Hiraguri M; Kishimoto K; Nakamura T; Adachi W; Miyabayashi H; Terai N; Amano J
    Surg Today; 2003; 33(4):294-8. PubMed ID: 12707827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma.
    Padjas A; Lesisz D; Lankoff A; Banasik A; Lisowska H; Bakalarz R; Góźdź S; Wojcik A
    Toxicol Appl Pharmacol; 2005 Dec; 209(2):183-91. PubMed ID: 15885733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
    Yanagawa H; Bando H; Takishita Y
    Anticancer Res; 1995; 15(2):613-6. PubMed ID: 7539241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of carboplatin/etoposide/vincristine with cisplatin/etoposide as combination chemotherapy for small cell lung cancer.
    Kumagai M; Kutsuzawa T; Fuyuno G; Kondo T; Shioya S; Ohta Y
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):209-14. PubMed ID: 8956462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
    Urban T; Chastang C; Lebas FX; Duhamel JP; Adam G; Darse J; Bréchot JM; Lebeau B
    Cancer; 1999 Dec; 86(11):2238-45. PubMed ID: 10590363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy for small cell lung cancer].
    Fukuoka M; Takada M; Masuda N; Furuse K; Saijo N; Ikegami H; Nishiwaki Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():225-31. PubMed ID: 7516450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic effects of etoposide (VP-16) on human lymphocytes; with special reference to the relation between sister chromatid exchange and chromatid breakage.
    Tominaga K; Shinkai T; Saijo N; Nakajima T; Ochi H; Suemasu K
    Jpn J Cancer Res; 1986 Apr; 77(4):385-91. PubMed ID: 3084428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].
    Abad-Esteve A; Rosell R; Moreno I; Fernández-Marcial C; Roselló M; Ribas Mundó M
    Med Clin (Barc); 1988 Apr; 90(14):569-72. PubMed ID: 2840536
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
    Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T
    Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CAV-PVP chemotherapy and sequential thoracic irradiation (TI) for patients with limited (LD) small cell lung cancer (SCLC)].
    Ueoka H; Ohnoshi T; Hiraki S; Kamei H; Tabata M; Shibayama T; Miyatake K; Gemba K; Hiyama J; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():218-24. PubMed ID: 8007469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sister chromatid exchanges induced in human lymphocytes by cis-diamminedichloroplatinum (II).
    Tominaga K; Shinkai T; Saijo N; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Nakajima T
    Jpn J Clin Oncol; 1984 Dec; 14(4):659-65. PubMed ID: 6542944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y; Inoue K; Hara N
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of small cell lung cancer].
    Komiya T; Takada M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.